I don’t agree. GNBT has been both ambitious and cash-strapped. They live in that gray space between pushing forward in an uncertain environment (covid, SEC) and not having a certain stream of funding to get things done in the shortest time possible. Investors forget that that the company is continually faced with these challenges, challenges for which they have limited or no solutions. It’s just where things are. It doesn’t mean that the company and its employees are failing, laying down on the job etc. This runs smack into investors anxiety about the future of their investment. Nobody is wrong. It is the story of OTC enterprises. Like everyone on this board game I long for good news, certainty and rising share value. I also share the desire for a corporate update, even if it’s only ‘we don’t have any money to push projects forward, and we don’t know when we will have money.’ I for one would be happy to hear even that.
(7)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links